semaglutide to tirzepatide transition Switching between weight-loss medications Switching from semaglutide to tirzepatide

Hormonal Changes Alongside changes in metabolism, weight loss can trigger hormonal adjustments that can impact appetite and satiety

No alcohol, tobacco, or substance use

Instead, it manufactures compounded medications that are distributed through healthcare providers, telehealth platforms, and pharmacy networks

Start your intake GLP-1 Availability in Canada: Current Supply and Cost Barriers Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) remain tightly rationed across Canada's provincial health systems

It is available only by prescription, and outside that approved indication it is prescribed off-label and often dispensed as a compounded preparation through 503A/503B compounding pharmacies for bodybuilding, fat-loss, or anti-aging purposes, uses the FDA has not evaluated or approved

Revised: 06/2026 Package/Label Display Panel 0.25 mg Pen NDC 0169-4525-14 List 452514 0.25 mg wegovy (semaglutide) injection 0.25 mg/0.5 mL Use Wegovy 1 time a week 4 Single-Dose Prefilled Pens Each pen delivers a single dose of 0.25 mg semaglutide For subcutaneous use only Single-Dose only Rx only Contains: 4 Wegovy pens, Product Literature